- Investor's Business Daily•3 days ago
Roche, Merck and Pfizer will likely disappoint on 2017 guidance, but AbbVie stock remains a "top pick" for Jefferies analyst Jeffrey Holford.
- TheStreet.com•3 days ago
Nike, Disney and Amgen shares struggled in 2016. Here is why they are ready to rebound in 2017.
- Motley Fool•4 days ago
Bargain-hunters can start off the year by taking a deeper look at these three promising healthcare stocks.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||152.65 x 100|
|Ask||154.90 x 200|
|Day's Range||153.83 - 155.35|
|52 Week Range||133.64 - 176.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||15.48|
|Dividend & Yield||4.60 (2.97%)|
|1y Target Est||N/A|